James FieldFounder

United Kingdom - London, England

𝐋𝐀𝐁𝐆𝐄𝐍𝐈𝐔𝐒
⚡The next wave of major scientific breakthroughs will be unlocked by combining the very best of human ingenuity 🧠💡 and machine intelligence 🤖.⚡

At LabGenius, our mission is to accelerate the discovery of next-generation therapeutic antibodies 💊. To do this, we’re pioneering the development of a smart robotic platform that’s capable of designing, conducting and critically learning from its own experiments.

The LabGenius team is growing 🚀 and if you're a scientist 👩‍🔬👨‍🔬 looking to make an impact at the cutting edge of drug discovery, then please get in touch:

The LabGenius Careers Page:
➡️ https://lnkd.in/dwbAiQQV

___

Over my time as CEO of LabGenius our team has:
- raised >$30M in financing from top-tier venture capital firms (e.g. Lux Capital, Obvious Ventures, Atomico, Kindred, Gigafund, Backed VC, Airstreet Capital)
- assembled a group of 60 incredible scientists and engineers
- developed a cutting edge ML-driven protein engineering platform
- inked R&D deals with top biotech and pharma companies (e.g. Ablynx / Sanofi)

𝐃𝐄𝐄𝐏 𝐓𝐄𝐂𝐇 𝐈𝐍𝐕𝐄𝐒𝐓𝐈𝐍𝐆
- I am passionate about supporting other deep tech founders - especially those who are making the transition from scientist to CEO.
- I originally got into deep tech investing by backing incredible scientific founders who I had known for several years - e.g. Leo @ 𝐑𝐚𝐡𝐤𝐨 (https://rahko.ai/), Nick @ 𝐏𝐡𝐲𝐭𝐨𝐟𝐨𝐫𝐦 𝐋𝐚𝐛𝐬 (https://www.phytoformlabs.com/) and Max @ 𝐇𝐨𝐱𝐭𝐨𝐧 𝐅𝐚𝐫𝐦𝐬 (https://hoxtonfarms.com/).
- I now manage European deep tech investments for a US Family Office. We have made investments in several very impressive deep tech startups including 𝐎𝐜𝐡𝐫𝐞 𝐁𝐢𝐨 (https://www.ochre-bio.com/) and 𝐋𝐢𝐥𝐢𝐮𝐦𝐗 (https://www.liliumx.com/).

𝐓𝐇𝐄 𝐉𝐎𝐔𝐑𝐍𝐄𝐘
Before founding LabGenius, I completed an EPSRC-funded PhD at Imperial College London during which I developed a platform for targeted drug delivery using re-engineered protein nanocages. Prior to my PhD, I completed a BSc in Biology with Microbiology (1st Class) and an MRes in Systems and Synthetic Biology (Distinction), at Imperial College London.

In 2017, I was awarded the BBSRC Innovator of the Year award for early career impact. I am also a fellow of the prestigious Synthetic Biology Leadership Excellence Accelerator Program (LEAP).

In 2018, I was featured on the Forbes 30 Under 30 list for Science & Healthcare.

𝐌𝐄
Outside of work, I enjoy time with my two wonderful children, reading science fiction and drinking loose leaf Earl Grey tea.